Immunocore Holdings (IMCR) Short-term Investments (2019 - 2026)

Immunocore Holdings has disclosed Short-term Investments across 4 years of filings, most recently posting $392.2 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $392.2 million, up 8.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $392.2 million (up 8.88% YoY), and the FY2025 annual result was $396.4 million, up 8.72% from the prior year.
• Short-term Investments came in at $392.2 million for Q1 2026 at Immunocore Holdings, down from $396.4 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $396.4 million in Q4 2025 to a low of $354.6 million in Q2 2024.
• The 3-year median for Short-term Investments is $378.4 million (2024), against an average of $377.5 million.
• Peak annual rise in Short-term Investments reached 11.36% in 2025, while the deepest fall reached 8.36% in 2025.
• Immunocore Holdings' Short-term Investments stood at $364.6 million in 2024, then gained by 8.72% to $396.4 million in 2025, then dropped by 1.06% to $392.2 million in 2026.
• The last three Short-term Investments figures came in at $392.2 million (Q1 2026), $396.4 million (Q4 2025), and $393.9 million (Q3 2025), per Business Quant data.